However, the data demonstrate that SARM protein expression is lower in RA monocytes from patients with active disease and could promote RA pathogenesis by lowering the inhibitory action of SARM on TLR1/2-induced IL-1β production. This evidence concerns the gene IL1B and rheumatoid arthritis.